Always Inspect Sample Integrity During Transit to Stability Chambers
Remember: GMP demands that samples transferred to stability chambers be verified for proper labeling, container condition, and documentation to maintain study validity.
Why This Matters in GMP
Stability testing plays a critical role in establishing the shelf life, storage conditions, and quality profile of pharmaceutical products. Before reaching the stability chambers, samples must be handled carefully to preserve their identity and ensure data reliability. Any damage, mislabeling, or mishandling during transport can compromise the sample’s integrity, leading to invalid results, deviation investigations, or flawed product shelf-life conclusions. Thus, inspecting sample integrity—including label clarity, seal condition, and transit record accuracy—is essential under GMP.
Neglecting this step can introduce variability into long-term studies, affect regulatory submissions, and result in product recalls if stability data is later found to be compromised. Sample verification acts as a quality checkpoint in the chain of custody between production and the stability program.
Regulatory and Compliance Implications
FDA 21 CFR Part 211.166 outlines requirements for stability testing, including documentation and environmental control. EU GMP Chapter 6 and WHO GMP require traceable, verified handling of samples for testing purposes. Schedule M mandates that all
Implementation Best Practices
- Inspect samples for labeling accuracy (product name, batch number, quantity, date) before and after transport.
- Ensure containers are sealed, intact, and suitable for the intended storage conditions (e.g., humidity-tight, light-protected).
- Use a documented transport log that records date, time, handler’s name, and any visual observations.
- Train staff responsible for handling samples on specific SOPs governing sample transfer and verification.
- Immediately report and investigate any observed discrepancies, breakages, or labeling errors before loading into the chamber.
Regulatory References
- FDA 21 CFR Part 211.166 – Stability Testing Requirements
- EU GMP Chapter 6 – Quality Control and Sample Management
- WHO GMP – Handling of Stability Study Samples
- Schedule M – Stability Chamber Sample Documentation